SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-027539
Filing Date
2023-10-03
Accepted
2023-10-03 17:00:12
Documents
13
Period of Report
2023-10-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dffn20231003_8k.htm   iXBRL 8-K 34395
  Complete submission text file 0001437749-23-027539.txt   166417

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dffn-20231003.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20231003_def.xml EX-101.DEF 11424
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20231003_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20231003_pre.xml EX-101.PRE 11584
7 EXTRACTED XBRL INSTANCE DOCUMENT dffn20231003_8k_htm.xml XML 2543
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 231305011
SIC: 2834 Pharmaceutical Preparations